Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 15
Original Research
Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,527 | Dovepress* | 4,831+ | 131 | 4,962 | |
| PubMed Central* | 696 | 376 | 1,072 | ||
| Totals | 5,527 | 507 | 6,034 | ||
| *Since 20 October 2022 | |||||
View citations on PubMed Central and Google Scholar